Area of research
Hepatology · Infectious Diseases
Research interest
Research interests include Hepatitis C virus research, SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies, and COVID-19 epidemiological studies.
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Screening and vaccination against COVID-19 to minimise school closure: a modelling study
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France
SARS-CoV-2 variants and ending the COVID-19 pandemic
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France
<i>Nocardia</i> Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Age-specific mortality and immunity patterns of SARS-CoV-2
Estimating the burden of SARS-CoV-2 in France
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Human plague: An old scourge that needs new answers
Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study
Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE Study
Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study
How to optimize hepatitis C virus treatment impact on life years saved in resource‐constrained countries
Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)
Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt